Table 2
Lifetime risk of cancer reported in families with an identified mismatch repair mutation
Colorectal cancer (men)
28–75%
Colorectal cancer (women)
24–52%
Endometrial cancer
27–71%
Ovarian cancer
3–13%
Gastric cancer
2–13%
Urinary tract cancer
1–12%
Brain tumour
1–4%
Bile duct/gallbladder cancer
2%
Small-bowel cancer
4–7%